Abstract
About a year ago a new specific anti-allergic drug without bronchodilating properties was introduced in England: disodium cromoglycate (Intal, Lomudal).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altounyan, R. E. C.: Inhibition of experimental asthma by a new compound — Disodium Cromoglycate „Intal“ (R). Acta Allerg. 22, 485–490 (1967).
Cox, J. S.-G.: Disodium cromoglycate (FPL 670) (“Intal“): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 216, 1328–1329 (1967).
Pepys, J., F. E. Hargreave, M. Chan, and D. S. McCarthy: Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 1968 II, 134–137.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Booij-Noord, H., de Vries, K. (1969). Protection Tests on Allergen Challenge with Disodium Cromoglycate. In: Ulmer, W.T. (eds) Lungenkreislauf. Verhandlungen der Gesellschaft für Lungen- und Atmungsforschung, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-39770-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-662-39770-1_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-38849-5
Online ISBN: 978-3-662-39770-1
eBook Packages: Springer Book Archive